Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Dai-Dan

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 2
Average round size
info
The average size of a deal this fund participated in
$12M
Portfolio companies 2
Rounds per year 0.02
Lead investments 0
Key employees Soon
https://www.daidan.co.jp/
Osaka, Osaka Prefecture, Japan

Areas of investment

  • Medical
  • Pharmaceutical
  • Medical Device
  • Health Care
Look at other 50 related and similar funds Collapse list ↓
Fund NameLocation
Alticor Corporate Enterprises Ada, Michigan, United States
American Investment Holdings -
Aria Ventures Birmingham, Michigan, United States
Besunyen (Beijing Outsell Health) China, Guangdong, Wanchai
Casema -
Cogepa France, Ile-de-France, Paris
Dayli Partners Seoul, Seoul-t'ukpyolsi, South Korea
Double Feather Japan, Tokyo
East Africa Capital Partners Kenya, Nairobi, Nairobi Area
Key Principal Partners Cleveland, Ohio, United States
LAB Miami Ventures Florida, Miami, United States
Rage Capital -
Sage Venture Partners California, Los Angeles, United States
Saratoga Ventures California, Santa Clara, United States
Serica Partners -
Shunying Capital China, Guangdong, Zhuhai
Susquehanna International Group (SIG) Bala Cynwyd, Pennsylvania, United States
Triangle Peak Partners California, Carmel Valley, United States
By posting comments on our website you confirm and acknowledge that:

1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.

2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.

3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.

4. We can moderate comments at any time.

5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.

6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.

Agree

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Dai-Dan?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 2
Average round size 12M
Rounds per year 0.02
Peak activity year 2023
Lead investments 0
Group Appearance index 1.00
Crunchbase icon

Content report

The following text will be sent to our editors:

Send